• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿片类药物给药对手术切除治疗的犬皮肤肥大细胞瘤细胞学和组织病理学诊断的影响。

Τhe Effect of Opioid Administration on Cytologic and Histopathologic Diagnosis of Canine Cutaneous Mast Cell Tumors Treated by Surgical Excision.

作者信息

Marouda Christina, Anagnostou Tilemahos, Savvas Ioannis, Papazoglou Lysimachos G, Psalla Dimitra

机构信息

Laboratory of Pathology, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.

Unit of Anaesthesiology and Intensive Care, Companion Animal Clinic, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54627 Thessaloniki, Greece.

出版信息

Vet Sci. 2022 Apr 22;9(5):202. doi: 10.3390/vetsci9050202.

DOI:10.3390/vetsci9050202
PMID:35622730
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9143400/
Abstract

Mast cell tumor (MCT) is a frequent cutaneous tumor in dogs, with a variable biological behavior. Studies correlate cytologic and histopathologic features of MCTs with their biological behavior, prognosis, and response to treatment. The use of preoperative opioids is common in canine patients undergoing surgical removal of these tumors. Certain opioids can induce or downregulate mast cell degranulation and influence cancer progression. The aim of the present study was to investigate whether the administration of morphine or butorphanol during surgical excision of canine cutaneous MCTs affects their cytologic and histopathologic appearance, thus influencing cytologic and histopathologic grading. This was a prospective, blinded, randomized, cohort clinical study. Forty-five dogs with cutaneous MCTs were randomly allocated into three groups according to preanaesthetic medication: dexmedetomidine combined with morphine (group M) or butorphanol (group B) or normal saline (group C). Cytologic specimens and histopathologic samples were obtained both prior to and after surgery. Samples were graded according to Kiupel's and Patnaik's systems, examined immunohistochemically for Ki-67 protein (Ki-67) and c-kit proto-oncogene product (KIT) expression, and histochemically for argyrophilic nucleolar organizing regions (AgNORs). Based on both Kiupel's and Patnaik's systems, no statistically significant differences were noted concerning the number of cases with grading discrepancies in grades allocated prior to versus after surgery among the groups. The same applied for cytological grading and immunohistochemical and histochemical evaluation. It seems that administration of morphine or butorphanol as part of the preanesthetic medication for surgical removal of canine cutaneous mast cell tumors does not influence histopathologic and cytologic grading of MCTs.

摘要

肥大细胞瘤(MCT)是犬类常见的皮肤肿瘤,其生物学行为具有多样性。研究将MCT的细胞学和组织病理学特征与其生物学行为、预后及治疗反应相关联。在接受这些肿瘤手术切除的犬类患者中,术前使用阿片类药物很常见。某些阿片类药物可诱导或下调肥大细胞脱颗粒并影响癌症进展。本研究的目的是调查在犬类皮肤MCT手术切除过程中给予吗啡或布托啡诺是否会影响其细胞学和组织病理学外观,从而影响细胞学和组织病理学分级。这是一项前瞻性、盲法、随机、队列临床研究。45只患有皮肤MCT的犬根据麻醉前用药随机分为三组:右美托咪定联合吗啡(M组)或布托啡诺(B组)或生理盐水(C组)。在手术前后均获取细胞学标本和组织病理学样本。样本根据基佩尔(Kiupel)和帕特纳伊克(Patnaik)系统进行分级,免疫组织化学检测Ki-67蛋白(Ki-67)和c-kit原癌基因产物(KIT)表达,组织化学检测嗜银核仁组织区(AgNORs)。基于基佩尔和帕特纳伊克系统,各组术前与术后分级差异病例数未见统计学显著差异。细胞学分级以及免疫组织化学和组织化学评估情况相同。作为犬类皮肤肥大细胞瘤手术切除麻醉前用药一部分的吗啡或布托啡诺给药似乎不会影响MCT的组织病理学和细胞学分级。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cceb/9143400/36c617c47662/vetsci-09-00202-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cceb/9143400/c2b8f49df056/vetsci-09-00202-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cceb/9143400/36c617c47662/vetsci-09-00202-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cceb/9143400/c2b8f49df056/vetsci-09-00202-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cceb/9143400/36c617c47662/vetsci-09-00202-g002.jpg

相似文献

1
Τhe Effect of Opioid Administration on Cytologic and Histopathologic Diagnosis of Canine Cutaneous Mast Cell Tumors Treated by Surgical Excision.阿片类药物给药对手术切除治疗的犬皮肤肥大细胞瘤细胞学和组织病理学诊断的影响。
Vet Sci. 2022 Apr 22;9(5):202. doi: 10.3390/vetsci9050202.
2
Cutaneous Canine Mast Cell Tumor: The Use of Proliferative Markers (Ki-67 and Ki-67 × AgNOR) in Cytological Samples for Diagnosis and Prognosis.犬皮肤肥大细胞瘤:增殖标志物(Ki-67和Ki-67×AgNOR)在细胞学样本诊断和预后中的应用
Vet Sci. 2024 Jan 7;11(1):23. doi: 10.3390/vetsci11010023.
3
Analysis of risk factors for canine mast cell tumors based on the Kiupel and Patnaik grading system among dogs with skin tumors.基于 Kiupel 和 Patnaik 分级系统分析皮肤肿瘤犬的肥大细胞瘤的风险因素。
Open Vet J. 2021 Oct-Dec;11(4):619-634. doi: 10.5455/OVJ.2021.v11.i4.12. Epub 2021 Nov 11.
4
Prevalence of exon 11 internal tandem duplications in the C-KIT proto-oncogene in Australian canine mast cell tumours.澳大利亚犬肥大细胞瘤中C-KIT原癌基因第11外显子内部串联重复的患病率。
Aust Vet J. 2017 Oct;95(10):386-391. doi: 10.1111/avj.12636.
5
Inclusion of fibroblasts and collagen fibrils in the cytologic grading of canine cutaneous mast cell tumors.在犬皮肤肥大细胞瘤的细胞学分级中纳入成纤维细胞和胶原纤维。
Vet Clin Pathol. 2022 Sep;51(3):339-348. doi: 10.1111/vcp.13098. Epub 2022 Apr 13.
6
Histological classification and expression of markers of canine mast cell tumors.犬肥大细胞瘤的组织学分类及标志物表达
Vet World. 2020 Aug;13(8):1627-1634. doi: 10.14202/vetworld.2020.1627-1634. Epub 2020 Aug 18.
7
Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication.犬皮肤肥大细胞瘤中的细胞增殖:与c-KIT的关联及其在预后评估中的作用
Vet Pathol. 2007 May;44(3):298-308. doi: 10.1354/vp.44-3-298.
8
Comparison of serum tryptase as a diagnostic oncological marker in canine versus human mast cell neoplasms.比较犬与人类肥大细胞瘤的血清类胰蛋白酶作为诊断性肿瘤标志物。
Res Vet Sci. 2022 Dec 10;151:90-95. doi: 10.1016/j.rvsc.2022.05.008. Epub 2022 Jul 1.
9
Cytologic Criteria for Mast Cell Tumor Grading in Dogs With Evaluation of Clinical Outcome.犬肥大细胞瘤分级的细胞学标准及临床结果评估
Vet Pathol. 2016 Nov;53(6):1117-1123. doi: 10.1177/0300985816638721. Epub 2016 Mar 31.
10
Diagnosis and Prognosis of Canine Cutaneous Mast Cell Tumors.犬皮肤肥大细胞瘤的诊断与预后
Vet Clin North Am Small Anim Pract. 2019 Sep;49(5):819-836. doi: 10.1016/j.cvsm.2019.04.002. Epub 2019 Jun 6.

引用本文的文献

1
Cutaneous Canine Mast Cell Tumor: The Use of Proliferative Markers (Ki-67 and Ki-67 × AgNOR) in Cytological Samples for Diagnosis and Prognosis.犬皮肤肥大细胞瘤:增殖标志物(Ki-67和Ki-67×AgNOR)在细胞学样本诊断和预后中的应用
Vet Sci. 2024 Jan 7;11(1):23. doi: 10.3390/vetsci11010023.
2
Evaluation of Tumor Grade and Proliferation Indices before and after Short-Course Anti-Inflammatory Prednisone Therapy in Canine Cutaneous Mast Cell Tumors: A Pilot Study.犬皮肤肥大细胞瘤短疗程抗炎泼尼松治疗前后肿瘤分级及增殖指数的评估:一项初步研究
Vet Sci. 2022 Jun 7;9(6):277. doi: 10.3390/vetsci9060277.

本文引用的文献

1
Effects of morphine on histamine release from two cell lines of canine mast cell tumor and on plasma histamine concentrations in dogs with cutaneous mast cell tumor.吗啡对犬肥大细胞瘤两种细胞系组胺释放及皮肤肥大细胞瘤犬血浆组胺浓度的影响。
Am J Vet Res. 2021 Nov 26;82(12):1013-1018. doi: 10.2460/ajvr.20.08.0137.
2
Value, Limitations, and Recommendations for Grading of Canine Cutaneous Mast Cell Tumors: A Consensus of the Oncology-Pathology Working Group.犬皮肤肥大细胞瘤分级的价值、局限性和建议:肿瘤-病理学工作组的共识。
Vet Pathol. 2021 Sep;58(5):858-863. doi: 10.1177/03009858211009785. Epub 2021 Apr 23.
3
Canine mast cell tumors: diagnosis, treatment, and prognosis.
犬肥大细胞瘤:诊断、治疗与预后
Vet Med (Auckl). 2014 Aug 12;5:49-58. doi: 10.2147/VMRR.S41005. eCollection 2014.
4
Non-neuronal kappa-opioid receptor activation enhances epidermal keratinocyte proliferation, and modulates mast cell functions in human skin ex vivo.
J Dermatol. 2020 Aug;47(8):917-921. doi: 10.1111/1346-8138.15407. Epub 2020 Jun 14.
5
Mast Cell Degranulation and Fibroblast Activation in the Morphine-induced Spinal Mass: Role of Mas-related G Protein-coupled Receptor Signaling.吗啡诱导脊髓质团中肥大细胞脱颗粒和成纤维细胞激活:Mas 相关 G 蛋白偶联受体信号的作用。
Anesthesiology. 2019 Jul;131(1):132-147. doi: 10.1097/ALN.0000000000002730.
6
Diagnosis and Prognosis of Canine Cutaneous Mast Cell Tumors.犬皮肤肥大细胞瘤的诊断与预后
Vet Clin North Am Small Anim Pract. 2019 Sep;49(5):819-836. doi: 10.1016/j.cvsm.2019.04.002. Epub 2019 Jun 6.
7
Comparison between May-Grünwald-Giemsa and rapid cytological stains in fine-needle aspirates of canine mast cell tumour: Diagnostic and prognostic implications.犬肥大细胞瘤细针穿刺抽吸物中May-Grünwald-Giemsa染色与快速细胞学染色的比较:诊断及预后意义
Vet Comp Oncol. 2018 Dec;16(4):511-517. doi: 10.1111/vco.12409. Epub 2018 Jul 1.
8
Assessment of Canine Mast Cell Tumor Mortality Risk Based on Clinical, Histologic, Immunohistochemical, and Molecular Features.基于临床、组织学、免疫组织化学和分子特征评估犬肥大细胞瘤的死亡风险
Vet Pathol. 2018 Mar;55(2):212-223. doi: 10.1177/0300985817747325. Epub 2018 Jan 16.
9
Diagnostic accuracy of pre-treatment biopsy for grading cutaneous mast cell tumours in dogs.犬皮肤肥大细胞瘤分级的治疗前活检诊断准确性
Vet Comp Oncol. 2018 Jun;16(2):214-219. doi: 10.1111/vco.12346. Epub 2017 Aug 31.
10
Use of a 2-tier histologic grading system for canine cutaneous mast cell tumors on cytology specimens.在细胞学标本上对犬皮肤肥大细胞瘤使用两级组织学分级系统。
Vet Clin Pathol. 2016 Sep;45(3):477-83. doi: 10.1111/vcp.12387. Epub 2016 Aug 2.